Circulating osteoprotegerin is not removed through haemodialysis membrane.
نویسندگان
چکیده
Sir, We read with interest the study of Coen et al. [1], which suggested a possible relationship between circulating osteoprotegerin (OPG) and bone metabolism in uraemic patients. We also reported that circulating OPG levels were elevated in dialysis patients and that the elevated OPG levels returned to normal after kidney transplantation [2,3]. The data suggested a potential role of the kidney in OPG elimination. To further elucidate the kinetics of OPG in long-term dialysis patients, we examined whether OPG was removed by haemodialysis. Fifteen adult chronic haemodialysis patients without any residual renal function entered the study. None of them suffered from liver dysfunction. After the circuit was filled with the patients’ blood, samples were obtained from upstream of the high-flux polysulfon membrane haemodialyzer (PS 1.6U, Fresenius-Kawasumi, Tokyo, Japan) at the beginning (P) and the end (R) of the haemodialysis session, and from downstream of the dialyzer at the beginning (Q). The in vitro sieving coefficient of the polysulfon dialysis membrane was 0.79 for beta-2 microglobulin and was less than 0.01 for albumin at the condition of blood flow rate (QB)s200 mlumin and filtrate flow rate (QF)s10 mluminum. In addition to OPG, serum urea nitrogen (UN), beta-2 microglobulin, and albumin levels were simultaneously monitored as controls. Serum OPG concentration was assayed by an ELISA (Cosmo-Bio, Tokyo, Japan). The serum OPG levels in blood P, Q, and R samples were all comparable with each other, suggesting that OPG molecules were not removed through the polysulfon membrane at all. In contrast, serum UN and beta-2 microglobulin levels decreased in Q and R samples compared with P samples. Serum albumin showed a similar behaviour as that of OPG (Figure 1). The data indicated that circulating OPG was not removed through polysulfon haemodialysis membrane. The observation is compatible with the supposed size of OPG monomer (approximately 60 kDa) and homodimers in the circulation. Furthermore, such molecules seem unlikely to be eliminated through glomerular filtration in physiological condition.
منابع مشابه
PHARMA COKINETICS OF RECOMBINANT ERYTHROPOIETIN AND RED CELL METABOLISM IN HAEMODIALYSIS PATIENTS
The pharmacokinetics of recombinant human erythropoietin (rHuEpo) administered intravenously has been investigated in a group of five patients with chronic renal failure who were dialysis-dependent. The half-life of circulating erythropoietin decreased from 7.9±OA hr (mean ±SO) at the beginning of treatment to 6.2±O.6 hr after 6 weeks and 5A±O.9 hr after 4 months of treatment. In spite of t...
متن کاملEVect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages
Objective—Osteoprotegerin ligand (OPGL) is a newly discovered molecule, which is expressed by osteoblasts/bone stromal cells. This ligand and M-CSF are now known to be essential for osteoclast diVerentiation from marrow and circulating precursors. This study examined whether OPGL and its soluble receptor osteoprotegerin (OPG), influenced osteoclast formation from human arthroplasty derived macr...
متن کاملInfusible Platelet Membrane versus Conventional Platelet Concentrate: Benefits and Disadvantages
Blood transfusion centers are under considerable pressure to produce platelet concentrates with a shelf life limit of 3 to 5 days. Many approaches have been investigated experimentally to produce new hemostatically active platelet products that are capable of long term storage. In this article infusible platelet membrane will be explained as a platelet substitute versus conventional liquid-stor...
متن کاملHuman uraemic serum displays calcific potential in vitro that increases with advancing chronic kidney disease.
Vascular calcification (VC) strongly correlates with declining renal function and contributes to the high morbidity and mortality of patients with CKD (chronic kidney disease). It is closely regulated by circulating factors but little is known about the capacity of serum from patients to induce calcification outside the disease setting, which we now define as the calcific potential of serum. We...
متن کاملβ-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes
BACKGROUND Serum β-trace protein (βTP, MW 23-29 kDa) is a marker of GFR impairment in renal patients. Recent papers propose to predict residual renal function (RRF) in maintenance haemodialysis (MHD) patients from serum concentrations of βTP and other small proteins, avoiding the collection of urine. Few data are available on the removal of βTP in patients treated with dialysis membranes with d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
دوره 17 10 شماره
صفحات -
تاریخ انتشار 2002